Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.

BACKGROUND: Patients with Birt-Hogg-Dubé (BHD) syndrome harbor germline mutations in the BHD tumor suppressor gene that are associated with an increased risk for kidney cancer. BHD encodes folliculin, a protein that may interact with the energy- and nutrient-sensing 5'-AMP-activated protein kinase-mammalian target of rapamycin (AMPK-mTOR) signaling pathways. METHODS: We used recombineering methods to generate mice with a conditional BHD allele and introduced the cadherin 16 (KSP)-Cre transgene to target BHD inactivation to the kidney. Kidney cell proliferation was measured by BrdU incorporation and phospho-histone H3 staining. Kidney weight data were analyzed with Wilcoxon's rank-sum, Student's t, and Welch's t tests. Hematoxylin and eosin staining and immunoblot analysis and immunohistochemistry of cell cycle and signaling proteins were performed on mouse kidney cells and tissues. BHD knockout mice and kidney cells isolated from BHD knockout and control mice were treated with the mTOR inhibitor rapamycin. Mouse survival was evaluated by Kaplan-Meier analyses. All statistical tests were two-sided. RESULTS: BHD knockout mice developed enlarged polycystic kidneys and died from renal failure by 3 weeks of age. Targeted BHD knockout led to the activation of Raf-extracellular signal-regulated protein kinase (Erk)1/2 and Akt-mTOR pathways in the kidneys and increased expression of cell cycle proteins and cell proliferation. Rapamycin-treated BHD knockout mice had smaller kidneys than buffer-treated BHD knockout mice had (n = 4-6 mice per group, relative kidney/body weight ratios, mean = 4.64% vs 12.2%, difference = 7.6%, 95% confidence interval = 5.2% to 10.0%; P < .001) and longer median survival time (n = 4-5 mice per group, 41.5 vs 23 days; P = .0065 ). CONCLUSIONS: Homozygous loss of BHD may initiate renal tumorigenesis in the mouse. The conditional BHD knockout mouse may be a useful research model for dissecting multistep kidney carcinogenesis, and rapamycin may be considered as a potential treatment for Birt-Hogg-Dubé syndrome.

Pubmed ID: 18182616 RIS Download

Mesh terms: Animals | Antibiotics, Antineoplastic | Blotting, Southern | Cell Proliferation | Disease Models, Animal | Estrone | Fluorescent Antibody Technique | Gene Silencing | Genotype | Germ-Line Mutation | Immunoblotting | Immunohistochemistry | Kaplan-Meier Estimate | Kidney | Kidney Neoplasms | Mice | Mice, Knockout | Mitogen-Activated Protein Kinase 1 | Mitogen-Activated Protein Kinase 3 | Polycystic Kidney Diseases | Protein Kinases | Proto-Oncogene Proteins | Random Allocation | Reverse Transcriptase Polymerase Chain Reaction | Signal Transduction | Sirolimus | Syndrome | TOR Serine-Threonine Kinases | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NIDDK NIH HHS, Id: R01 DK067565
  • Agency: PHS HHS, Id: N01 C012400
  • Agency: NIDDK NIH HHS, Id: R37 DK042921
  • Agency: NIDDK NIH HHS, Id: P30 DK079328
  • Agency: NIDDK NIH HHS, Id: P30DK079328
  • Agency: NCI NIH HHS, Id: N01 CO012400
  • Agency: Intramural NIH HHS, Id: Z01 SC006659-25

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.